Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia.
Jihyun LeeSu Young JungMi-Yeon ChoiJi-Su ParkSu-Kyoung ParkSeon-Ah LimKyung Hee ChoSoo Yeon OhJungeun HaDong-Wook KimJangik I LeePublished in: Journal of clinical pharmacy and therapeutics (2020)
Radotinib CDBS are highly correlated with radotinib Cp. Radotinib Cp can be accurately and precisely predicted from CDBS using direct or Hct-corrected prediction methods. Both appear to be appropriate for the therapeutic monitoring of radotinib in patients with CML.